179 related articles for article (PubMed ID: 8742128)
21. Chinese achondroplasia is also defined by recurrent G380R mutations of the fibroblast growth factor receptor-3 gene.
Niu DM; Hsiao KJ; Wang NH; Chin LS; Chen CH
Hum Genet; 1996 Jul; 98(1):65-7. PubMed ID: 8682509
[TBL] [Abstract][Full Text] [Related]
22. Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia.
Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
Acta Paediatr Suppl; 1996 Oct; 417():33-8. PubMed ID: 9055906
[TBL] [Abstract][Full Text] [Related]
23. A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online.
Grigelioniené G; Hagenäs L; Eklöf O; Neumeyer L; Haereid PE; Anvret M
Hum Mutat; 1998; 11(4):333. PubMed ID: 10215410
[TBL] [Abstract][Full Text] [Related]
24. Mutation in the gene encoding the fibroblast growth factor receptor-3 in Korean children with achondroplasia.
Yang SW; Kitoh H; Yamada Y; Goto H; Ogasawara N
Acta Paediatr Jpn; 1998 Aug; 40(4):324-7. PubMed ID: 9745773
[TBL] [Abstract][Full Text] [Related]
25. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.
Chen L; Adar R; Yang X; Monsonego EO; Li C; Hauschka PV; Yayon A; Deng CX
J Clin Invest; 1999 Dec; 104(11):1517-25. PubMed ID: 10587515
[TBL] [Abstract][Full Text] [Related]
26. Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells.
Thompson LM; Raffioni S; Wasmuth JJ; Bradshaw RA
Mol Cell Biol; 1997 Jul; 17(7):4169-77. PubMed ID: 9199352
[TBL] [Abstract][Full Text] [Related]
27. Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts.
Nguyen HB; Estacion M; Gargus JJ
Hum Mol Genet; 1997 May; 6(5):681-8. PubMed ID: 9158142
[TBL] [Abstract][Full Text] [Related]
28. FGFR3 gene mutations in transmembrane domain in Chinese achondroplasia and hypochondroplasia patients.
Yan-Ling G; Ji-Hong N; Guo-Qiang L; Wei W; De-Fen W
Horm Res; 1998; 49 Suppl 1():57. PubMed ID: 9554479
[No Abstract] [Full Text] [Related]
29. Clinical and molecular characteristics of Thai patients with achondroplasia.
Shotelersuk V; Ittiwut C; Srivuthana S; Wacharasindhu S; Aroonparkmongkol S; Mutirangura A; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):429-33. PubMed ID: 11556601
[TBL] [Abstract][Full Text] [Related]
30. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors.
Li C; Chen L; Iwata T; Kitagawa M; Fu XY; Deng CX
Hum Mol Genet; 1999 Jan; 8(1):35-44. PubMed ID: 9887329
[TBL] [Abstract][Full Text] [Related]
31. [Association of achondroplasia to a mutation in the transmembrane domain of fibroblastic growth factor receptor 3 (FGFR3)].
Rousseau F; Bonaventure J; Le Merrer M; Munnich A
Ann Endocrinol (Paris); 1996; 57(3):151-2. PubMed ID: 8949407
[No Abstract] [Full Text] [Related]
32. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
[TBL] [Abstract][Full Text] [Related]
33. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.
Wang Y; Spatz MK; Kannan K; Hayk H; Avivi A; Gorivodsky M; Pines M; Yayon A; Lonai P; Givol D
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4455-60. PubMed ID: 10200283
[TBL] [Abstract][Full Text] [Related]
34. Genotype phenotype correlation in achondroplasia and hypochondroplasia.
Matsui Y; Yasui N; Kimura T; Tsumaki N; Kawabata H; Ochi T
J Bone Joint Surg Br; 1998 Nov; 80(6):1052-6. PubMed ID: 9853502
[TBL] [Abstract][Full Text] [Related]
35. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
van Ravenswaaij-Arts CM; Losekoot M
Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167
[TBL] [Abstract][Full Text] [Related]
36. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation.
Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W
South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data.
Tsai FJ; Tsai CH; Chang JG; Wu JY
Am J Med Genet; 1999 Sep; 86(3):300-1. PubMed ID: 10482885
[No Abstract] [Full Text] [Related]
39. The genetic basis of dwarfism.
Francomano CA
N Engl J Med; 1995 Jan; 332(1):58-9. PubMed ID: 7990869
[No Abstract] [Full Text] [Related]
40. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
Colvin JS; Bohne BA; Harding GW; McEwen DG; Ornitz DM
Nat Genet; 1996 Apr; 12(4):390-7. PubMed ID: 8630492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]